MSc Precision Medicine (Cancer) at University of Brighton

This MSc gives pharmacy, biochemistry, biomedical and biology graduates the opportunity to help shape the future of healthcare, through the study of precision medicine and oncology. Precision medicine personalises disease prevention and treatment, considering the differences in people’s genes, environments, and lifestyles to target the right treatments, to the right patients, at the right time.

Faculty: School of Applied Sciences  |  Department: Biomedical Science  |  Duration: full-time: 1 year; part-time: 2 years  |  Study mode: full-time / part-time  |  Location: Brighton, England, United Kingdom

What you will study

The Precision Medicine (Cancer) MSc is typically completed full-time in one year, but can be taken part-time over two years. The teaching approach integrates systems, enquiry and case-based learning and is structured to include both taught modules, a placement and a project. To be awarded the MSc, you must obtain 180 M-level credits: 120 credits from taught and subject-specific modules, and 60 credits through the completion of the project. Syllabus Modules include Omics for Diseases: Theory, Practice and Applications, Cancer: Bench to Bedside, Psycho-oncology, Precision Medicine, Precision Medicine Project, Research Fundamentals.

Career pathways

An MSc in Precision Medicine (Cancer) at Brighton prepares you to work at the cutting edge of personalised healthcare, where treatments are tailored to the unique genetic and molecular characteristics of each patient. You’ll gain advanced skills in oncology, tumour profiling, omics technologies and biomarker discovery, making you well‑equipped for specialist roles across healthcare, research and biotech.

Official programme page